Vimarsana
Biggest News Aggregation in the World

Page 19 - Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contract Development Today - Breaking & Trending Today

Small Molecule Innovator Cdmo Market Poised For Substantial Growth, Forecasted To Surpass USD 84.7 B - Vimarsana News

Small Molecule Innovator Cdmo Market Poised For Substantial Growth, Forecasted To Surpass USD 84.7 B

Marketresearch.biz reports that the global small molecule innovator CDMO market revenue is expected to increase to USD 84.7 Bn in 2032 from USD 45.4 Bn in 2022, and register a revenue CAGR of 6.6% during the forecast period (2023 to 2032).Overview of the Small Molecule Innovator CDMO MarketThe Small Molecule Innovat...

3 medtech acquisition developments in Q1 - Vimarsana News

3 medtech acquisition developments in Q1

Three spine and orthopedic medtech companies provided updates related to acquisitions during the first quarter of 2024.

PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow - Vimarsana News

PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow

PolyPeptide Group / Key word: Annual Results PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash...

Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion) - Vimarsana News

Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)

/PRNewswire/ -- Novo Holdings today announced its financial results for 2023*. Strong Investment Portfolio performance, and growth of the Novo Group companies...

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript - Vimarsana News

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.